Tumors originate due to mutations in oncogene/tumor suppressor genes in which abnormal activity or inactivity transforms cells from normal to tumor. However, oncogne-driver mutations do not fully explain the emergence of tumors.
In this webinar, Dr. Katerina Gurova, Roswell Park Cancer Institute, describes how she used scRNA-Seq to examine whether the transition between one epigenetic state into another makes cells vulnerable to oncogene induced transformation.
What you'll learn:
- More about the Gurova Lab and how they are identifying new ways to get ahead of cancer.
- How single cell RNA sequencing (scRNA-seq) can be used to identify what makes cells vulnerable to oncogene induced transformation.
- More about the Evercode split-pool combinatorial barcoding platform from Parse Biosciences.